Biogen Inc (BIIB) Event July 20, 2022, 11:04 UTC (10% Negative) BIOGEN INC. (BIIB) Reports Q3 2022 Financial Results Full text
Register to leave comments News bot Oct. 2, 2025, 3:44 p.m. 📋 BIOGEN INC. (BIIB) - Financial Results Filing Date: 2022-07-20 Accepted: 2022-07-20 07:04:19 Event Type: Financial Results Event Details: Biogen Inc (BIIB) Reports Q3 2022 Financial Results Biogen Inc (BIIB) announced its financial results for the period ending Q3 2022. Key Financial Highlights: Revenue: $2,589 million Net Income: (1.99) EPS: 5.25 Cash and equivalents: $737 million expected in the second half of 2022expected in the Fall of 2022expected by January 6, 2023 📊 Key Financial Metrics: Metric Value Eps 5.25 Net Income (1.99) Revenue $2,589 million Cash $737 million 💼 Business Developments: PartnershipAcquisitionLicensingRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Biogen IncCIK: 0000875045Ticker Symbol: BIIBPeriod End Date: 2022-07-20Document Type: 8-K
📋 BIOGEN INC. (BIIB) - Financial Results
Filing Date: 2022-07-20
Accepted: 2022-07-20 07:04:19
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
Structured Data: